Invention Grant
- Patent Title: Modified serotype 28 adenoviral vectors
-
Application No.: US14403651Application Date: 2013-05-28
-
Publication No.: US09790519B2Publication Date: 2017-10-17
- Inventor: Lisa Wei , Douglas E. Brough , C. Richter King
- Applicant: GenVec, Inc.
- Applicant Address: US MD Gaithersburg
- Assignee: GenVec, Inc.
- Current Assignee: GenVec, Inc.
- Current Assignee Address: US MD Gaithersburg
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2013/042824 WO 20130528
- International Announcement: WO2013/181128 WO 20131205
- Main IPC: C12N15/861
- IPC: C12N15/861 ; C12N15/00 ; A61K48/00 ; C12N15/86
Abstract:
The invention provides a replication-deficient serotype 28 adenoviral vector characterized by comprising a portion of a serotype 45 adenoviral hexon protein and/or a portion of a serotype 45 fiber protein in place of the endogenous serotype 28 hexon and/or fiber protein.
Public/Granted literature
- US20150167018A1 MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS Public/Granted day:2015-06-18
Information query
IPC分类:
